Enveric Biosciences Inc Strategic Asset Allocation Index
Enveric Biosciences Inc strategic asset allocation index. Enveric Biosciences Inc (ENVB) has a Strategic Asset Allocation Index of 12.4% as of June 2023. Strategic assets (PP&E of $604.84K plus long-term investments of $-) total $604.84K, measured against net assets of $4.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ENVB equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Enveric Biosciences Inc (2021–2021)
Strategic asset allocation index of Enveric Biosciences Inc from 2021 to 2021. This chart shows how Enveric Biosciences Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 12.4%, representing strategic assets of $604.84K against net assets of $4.87 Million USD. Check Enveric Biosciences Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Enveric Biosciences Inc Strategic Asset Allocation Index by Year (2021–2021)
Enveric Biosciences Inc strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Enveric Biosciences Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ENVB company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 2.1% | $470.73K | $470.73K | $- | $22.31 Million | — |